| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Psychiatry (Drs. Breitner, Welsh, Plassman, and McDonald, Ms. Gau, and Mr. Helms), the Center for the Study of Aging and Human Development (Dr. Breitner), and the Joseph and Kathleen Bryan Alzheimer's Disease Research Center (Drs. Breitner and Welsh), Duke University Medical Center, Durham, NC, and the Departments of Mental Hygiene and Epidemiology (Dr. Anthony), the Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD.
We conducted a co-twin control study among 50 elderly twin pairs with onsets of Alzheimer's disease (AD) separated by 3 or more years. Twenty-three male pairs (46%) were screened from the (U.S.) National Academy of Sciences-National Research Council Registry (NAS-NRC Registry) of World War II veteran twins; others (mostly women) had responded to advertisements or were referred from AD clinics. Twenty-six pairs (52%) were monozygous. The onset of AD was inversely associated with prior use of corticosteroids or ACTH (odds ratio [OR], 0.25; 95% confidence interval [CI], 0.06 to 0.95; p = 0.04). Similar but weaker trends were present among pairs discordant for history of arthritis or for prior daily use of nonsteroidal anti-inflammatory drugs (NSAIDs) or aspirin. The association was strongest when we combined use of steroids/ACTH or NSAIDs post hoc into a single variable of anti-inflammatory drugs (AIs) (OR, 0.24; CI, 0.07 to 0.74; p = 0.01). The inverse relation was strong in female (volunteer) twin pairs but was not present in the younger men from the NAS-NRC Registry. AIs had typically been taken for arthritis or related conditions, but a similar result was apparent after controlling statistically for the arthritis variable (OR, 0.08; CI, 0.01 to 0.69; p = 0.02). AIs have been proposed as a means of retarding the progression of AD symptoms, and these data suggest that AIs may also prevent or delay the initial onset of AD symptoms. Because of limitations in the case-control method, our results require corroboration with hypothesis-driven research designed to control bias and confounding.
Address correspondence and reprint requests to Dr. John C.S. Breitner, PO Box 3925, Duke University Medical Center, Durham, NC 27710.
Supported by NIH grants AG-05128, AG-07922, and AG-08549, by the Alzheimer's Association, and by the Sandoz Foundation for Gerontologic Research.
Received August 9, 1993. Accepted for publication in final form August 19,1993.
This article has been cited by other articles:
|
|
 |
|
  Z. Arvanitakis, F. Grodstein, J. L. Bienias, J. A. Schneider, R. S. Wilson, J. F. Kelly, D. A. Evans, and D. A. Bennett Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology Neurology, June 3, 2008; 70(23): 2219 - 2225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tahara, H.-D. Kim, J.-J. Jin, J. A. Maxwell, L. Li, and K.-i. Fukuchi Role of toll-like receptor signalling in A{beta} uptake and clearance Brain, November 1, 2006; 129(11): 3006 - 3019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Abrous, M. Koehl, and M. Le Moal Adult Neurogenesis: From Precursors to Network and Physiology Physiol Rev, April 1, 2005; 85(2): 523 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. M. de Craen, J. Gussekloo, B. Vrijsen, and R. G. J. Westendorp Meta-Analysis of Nonsteroidal Antiinflammatory Drug Use and Risk of Dementia Am. J. Epidemiol., January 15, 2005; 161(2): 114 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Glezer and S. Rivest Glucocorticoids: Protectors of the Brain during Innate Immune Responses Neuroscientist, December 1, 2004; 10(6): 538 - 552. [Abstract] [PDF]
|
|
|
|
|
|
E. van Exel, A. J.M. de Craen, E. J. Remarque, J. Gussekloo, P. Houx, A. Bootsma-van der Wiel, M. Frolich, P. W. Macfarlane, G. J. Blauw, and R. G.J. Westendorp Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function Neurology, December 23, 2003; 61(12): 1695 - 1701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Etminan, S. Gill, and A. Samii Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies BMJ, July 17, 2003; 327(7407): 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shibata, T. Yamada, T. Ishii, S. Kumazawa, H. Nakamura, H. Masutani, J. Yodoi, and K. Uchida Thioredoxin as a Molecular Target of Cyclopentenone Prostaglandins J. Biol. Chem., July 3, 2003; 278(28): 26046 - 26054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Landi, M. Cesari, G. Onder, A. Russo, S. Torre, and R. Bernabei Non-Steroidal Anti-Inflammatory Drug (NSAID) Use and Alzheimer Disease in Community-Dwelling Elderly Patients Am J Geriatr Psychiatry, April 1, 2003; 11(2): 179 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. in 't Veld, L. J. Launer, M. M. B. Breteler, A. Hofman, and B. H. Ch. Stricker Pharmacologic Agents Associated with a Preventive Effect on Alzheimer's Disease: A Review of the Epidemiologic Evidence Epidemiol. Rev., December 1, 2002; 24(2): 248 - 268. [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Prasad, W. C. Cole, and K. C. Prasad Risk Factors for Alzheimer's Disease: Role of Multiple Antioxidants, Non-Steroidal Anti-inflammatory and Cholinergic Agents Alone or in Combination in Prevention and Treatment J. Am. Coll. Nutr., December 1, 2002; 21(6): 506 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Zandi, J. C. Anthony, K. M. Hayden, K. Mehta, L. Mayer, and J. C.S. Breitner Reduced incidence of AD with NSAID but not H2 receptor antagonists: The Cache County Study Neurology, September 24, 2002; 59(6): 880 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Suh and F. Checler Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease Pharmacol. Rev., September 1, 2002; 54(3): 469 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ryu, K.-j. Min, T. Y. Rhim, T. H. Kim, H. Pyo, B. Jin, S.-U. Kim, I. Jou, S. S. Kim, and E.-h. Joe Prothrombin Kringle-2 Activates Cultured Rat Brain Microglia J. Immunol., June 1, 2002; 168(11): 5805 - 5810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.C. de la Torre Alzheimer Disease as a Vascular Disorder: Nosological Evidence Stroke, April 1, 2002; 33(4): 1152 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. in 't Veld, A. Ruitenberg, A. Hofman, L. J. Launer, C. M. van Duijn, T. Stijnen, M. M.B. Breteler, and B. H.C. Stricker Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease N. Engl. J. Med., November 22, 2001; 345(21): 1515 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L Tyas, J. Manfreda, L. A Strain, and P. R Montgomery Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada Int. J. Epidemiol., June 1, 2001; 30(3): 590 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Bigler, C. M. Lowry, C. V. Anderson, S. C. Johnson, J. Terry, and M. Steed Dementia, Quantitative Neuroimaging, and Apolipoprotein E Genotype AJNR Am. J. Neuroradiol., November 1, 2000; 21(10): 1857 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Huffman and M. E. Kunik Assessment and Understanding of Pain in Patients With Dementia Gerontologist, October 1, 2000; 40(5): 574 - 581. [Abstract] [Full Text]
|
|
|
|
|
|
P. S. Aisen, K. L. Davis, J. D. Berg, K. Schafer, K. Campbell, R. G. Thomas, M. F. Weiner, M. R. Farlow, M. Sano, M. Grundman, et al. A randomized controlled trial of prednisone in Alzheimer's disease Neurology, February 8, 2000; 54(3): 588 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. R. A. Mackenzie Anti-inflammatory drugs and Alzheimer-type pathology in aging Neurology, February 8, 2000; 54(3): 732 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Nourhashemi, S. Gillette-Guyonnet, S. Andrieu, A. Ghisolfi, P. J. Ousset, H. Grandjean, A. Grand, J. Pous, B. Vellas, and J.-L. Albarede Alzheimer disease: protective factors1 Am. J. Clinical Nutrition, February 1, 2000; 71(2): 643s - 649s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Lerner Alzheimer's Disease in Males: Endocrine Issues and Prospects J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3416 - 3419. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Shua-Haim and J. S. Ross Current and the near future medications for Alzheimer's disease: What can we expect from them? American Journal of Alzheimer's Disease and Other Dementias, September 1, 1999; 14(5): 294 - 307. [PDF]
|
|
|
|
 |
|
 O. Felician and T. A. Sandson The Neurobiology and Pharmacotherapy of Alzheimer's Disease J Neuropsychiatry Clin Neurosci, February 1, 1999; 11(1): 19 - 31. [Abstract] [Full Text]
|
|
|
|
 |
|
 I Räihä, J Kaprio, M Koskenvuo, T Rajala, and L Sourander Environmental differences in twin pairs discordant for Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, November 1, 1998; 65(5): 785 - 787. [Abstract] [Full Text]
|
|
|
|
|
|
G. M. Murphy Jr., L. Yang, and B. Cordell Macrophage Colony-stimulating Factor Augments beta -Amyloid-induced Interleukin-1, Interleukin-6, and Nitric Oxide Production by Microglial Cells J. Biol. Chem., August 14, 1998; 273(33): 20967 - 20971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. V Bowler, D. G Munoz, H. Merskey, and V. Hachinski Factors affecting the age of onset and rate of progression of Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, August 1, 1998; 65(2): 184 - 190. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. R. de Kloet, E. Vreugdenhil, M. S. Oitzl, and M. Joëls Brain Corticosteroid Receptor Balance in Health and Disease Endocr. Rev., June 1, 1998; 19(3): 269 - 301. [Abstract] [Full Text]
|
|
|
|
|
|
H. C. Hendrie Epidemiology of Dementia and Alzheimer's Disease Am J Geriatr Psychiatry, May 1, 1998; 6(2): 3S - 18. [Abstract] [Full Text]
|
|
|
|
|
|
O.-Y. So, L. E. Scarafia, A. Y. Mak, O. H. Callan, and D. C. Swinney The Dynamics of Prostaglandin H Synthases. STUDIES WITH PROSTAGLANDIN H SYNTHASE 2 Y355F UNMASK MECHANISMS OF TIME-DEPENDENT INHIBITION AND ALLOSTERIC ACTIVATION J. Biol. Chem., March 6, 1998; 273(10): 5801 - 5807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. V Bowler, D. G Munoz, H. Merskey, and V. Hachinski Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, January 1, 1998; 64(1): 18 - 24. [Abstract] [Full Text]
|
|
|
|
|
|
D. C. Swinney, A. Y. Mak, J. Barnett, and C. S. Ramesha Differential Allosteric Regulation of Prostaglandin H Synthase 1 and 2 by Arachidonic Acid J. Biol. Chem., May 9, 1997; 272(19): 12393 - 12398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Backstrom, G. P. Lim, M. J. Cullen, and Z. A. Tokes Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-beta Peptide (1-40) J. Neurosci., December 15, 1996; 16(24): 7910 - 7919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Giulian, L. J. Haverkamp, J. H. Yu, W. Karshin, D. Tom, J. Li, J. Kirkpatrick, Y.-M. Kuo, and A. E. Roher Specific Domains of beta -Amyloid from Alzheimer Plaque Elicit Neuron Killing in Human Microglia J. Neurosci., October 1, 1996; 16(19): 6021 - 6037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bitting, A. Naidu, B. Cordell, and G. M. Murphy Jr. beta -Amyloid Peptide Secretion by a Microglial Cell Line Is Induced by beta -Amyloid-(25-35) and Lipopolysaccharide J. Biol. Chem., July 5, 1996; 271(27): 16084 - 16089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ryu, H. Pyo, I. Jou, and E. Joe Thrombin Induces NO Release from Cultured Rat Microglia via Protein Kinase C, Mitogen-activated Protein Kinase, and NF-kappa B J. Biol. Chem., September 22, 2000; 275(39): 29955 - 29959. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
